Filter News
Area of Research
- (-) Clean Energy (37)
- (-) Materials (24)
- Advanced Manufacturing (3)
- Biology and Environment (16)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (1)
- Materials for Computing (4)
- National Security (14)
- Neutron Science (15)
- Nuclear Science and Technology (2)
- Quantum information Science (1)
- Supercomputing (40)
News Topics
- (-) Biomedical (4)
- (-) Clean Water (1)
- (-) Coronavirus (4)
- (-) Cybersecurity (4)
- (-) Machine Learning (5)
- (-) Quantum Science (10)
- (-) Summit (3)
- (-) Sustainable Energy (25)
- 3-D Printing/Advanced Manufacturing (33)
- Advanced Reactors (3)
- Artificial Intelligence (6)
- Big Data (1)
- Bioenergy (17)
- Biology (6)
- Biotechnology (2)
- Buildings (8)
- Chemical Sciences (20)
- Climate Change (8)
- Composites (6)
- Computer Science (13)
- Critical Materials (10)
- Decarbonization (11)
- Energy Storage (36)
- Environment (17)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (2)
- Fusion (2)
- Grid (10)
- High-Performance Computing (4)
- Isotopes (5)
- ITER (1)
- Materials (44)
- Materials Science (39)
- Mercury (1)
- Microscopy (12)
- Molten Salt (2)
- Nanotechnology (22)
- National Security (5)
- Net Zero (1)
- Neutron Science (23)
- Nuclear Energy (5)
- Partnerships (11)
- Physics (14)
- Polymers (9)
- Quantum Computing (1)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Transformational Challenge Reactor (3)
- Transportation (18)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.